Sunday, October, 25, 2009
Schizophrenia
November 19, 2008
This is a study to compare the effects of a new drug for schizophrenia (AL-108) to a placebo in people suffering from schizophrenia. Researchers will focus on the new medication's effects on the cognitive problems associated with schizophrenia when it is added to the patients' existing treatments. This study is currently recruiting 60 schizophrenia patients from eight states to participate in this 12-week clinical trial.
Read more »
Expert & Community Posts
By Jerry Kennard
,
Health Expert
...if you only have a passing interest in the latest schizophrenia research news, one thing stands...
Read more »
By Paul Ballas
,
Health Expert
......problems in brain functions. Generally people see schizophrenia as an illness of...
Read more »
By Paul Ballas
,
Health Expert
......discuss some issues in the treatment of childhood onset schizophrenia. First, it should be...
Read more »
By Jerry Kennard
,
Health Expert
...genetic discovery that could help solve the puzzle of schizophrenia and in so doing offer the...
Read more »
Health Guide
Schizophrenia Connections thrives because individuals like you are willing and eager to share their experience--and expertise--with others coping with the illness. If you are experiencing...
Read more »
...Planning. Robins accomplishments are unusual given that from the age of thirteen, he has suffered from
schizophrenia, perhaps the most devastating of all mental illnesses.
Schizophrenia is a...
Read more »
...repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in
schizophrenia: a meta-analysis. J Clin Psychiatry. 2007 Mar;68(3):416-21.Crespo-Facorro B,...
Read more »
......resonance imaging (MRI) have shown a number of abnormalities in the brain's structure associated with
schizophrenia. Such problems can cause nerve damage and disconnections in the pathways that...
Read more »
Related News
July 06, 2009
(Ivanhoe Newswire) -- A new study finds people with schizophrenia die from cancer four times as often as people in the general population....
Read summary »
April 15, 2009
U.S. researchers say they've spotted a gene variant that may raise the risk of schizophrenia in some people, a finding that may lead to new...
Read summary »
October 03, 2008
An experimental schizophrenia medication has shown positive results in human trials. Schizophrenia patients in the study who were given the...
Read summary »
August 17, 2009
The U.S. Food and Drug Administration has approved the drug Saphris (asenapine) to treat adults with either schizophrenia or bipolar I disorder.
Read summary »
July 30, 2009
Phase III clinical trials on a new drug to treat schizophrenia have been stopped, its makers report. Officials with drugmakers Lundbeck and Solvay...
Read summary »